Location of Repository

Modulation of CaV1.2 Channels by Mg2+ Acting at an EF-hand Motif in the COOH-terminal Domain

By Sylvain Brunet, Todd Scheuer, Rachel Klevit and William A. Catterall


Magnesium levels in cardiac myocytes change in cardiovascular diseases. Intracellular free magnesium (Mgi) inhibits L-type Ca2+ currents through CaV1.2 channels in cardiac myocytes, but the mechanism of this effect is unknown. We hypothesized that Mgi acts through the COOH-terminal EF-hand of CaV1.2. EF-hand mutants were engineered to have either decreased (D1546A/N/S/K) or increased (K1543D and K1539D) Mg2+ affinity. In whole-cell patch clamp experiments, increased Mgi reduced both Ba2+ and Ca2+ currents conducted by wild type (WT) CaV1.2 channels expressed in tsA-201 cells with similar affinity. Exposure of WT CaV1.2 to lower Mgi (0.26 mM) increased the amplitudes of Ba2+ currents 2.6 ± 0.4–fold without effects on the voltage dependence of activation and inactivation. In contrast, increasing Mgi to 2.4 or 7.2 mM reduced current amplitude to 0.5 ± 0.1 and 0.26 ± 0.05 of the control level at 0.8 mM Mgi. The effects of Mgi on peak Ba2+ currents were approximately fit by a single binding site model with an apparent Kd of 0.65 mM. The apparent Kd for this effect of Mgi was shifted ∼3.3- to 16.5-fold to higher concentration in D1546A/N/S mutants, with only small effects on the voltage dependence of activation and inactivation. Moreover, mutant D1546K was insensitive to Mgi up to 7.2 mM. In contrast to these results, peak Ba2+ currents through the K1543D mutant were inhibited by lower concentrations of Mgi compared with WT, consistent with approximately fourfold reduction in apparent Kd for Mgi, and inhibition of mutant K1539D by Mgi was also increased comparably. In addition to these effects, voltage-dependent inactivation of K1543D and K1539D was incomplete at positive membrane potentials when Mgi was reduced to 0.26 or 0.1 mM, respectively. These results support a novel mechanism linking the COOH-terminal EF-hand with modulation of CaV1.2 channels by Mgi. Our findings expand the repertoire of modulatory interactions taking place at the COOH terminus of CaV1.2 channels, and reveal a potentially important role of Mgi binding to the COOH-terminal EF-hand in regulating Ca2+ influx in physiological and pathophysiological states

Topics: Article
Publisher: The Rockefeller University Press
OAI identifier: oai:pubmedcentral.nih.gov:2266622
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (1990). A non-specific Ca2 (or Mg2 )-stimulated ATPase in rat heart sarcoplasmic reticulum.
    2. (1994). A practical guide to the preparation of Ca2 buffers.
    3. (2003). Adrenergic regulation requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper interaction with A kinase-anchoring protein 15.
    4. (1993). Block of the L-type Ca2 channel pore by external and internal Mg2 in rat phaeochromocytoma cells.
    5. (1991). Calcium binding induces conformational changes in muscle regulatory proteins. Trends Biochem.
    6. (1994). Calcium-binding proteins. 1: EF-hands. Protein Profile.
    7. (1999). Calmodulin supports both inactivation and facilitation of L-type calcium channels.
    8. (1991). Characterisation of the two size forms of the 1 subunit of skeletal L-type calcium channels.
    9. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    10. Critical determinants of Ca2 -dependent inactivation within an EF- hand motif of L-type Ca2 channels.
    11. (1991). Cytosolic free magnesium in stimulated, hypoxic, and underperfused rat heart.
    12. (1989). Cytosolic free magnesium levels in ischemic rat heart.
    13. (2002). Cytosolic free magnesium modulates Na/Ca exchange currents in pig myocytes.
    14. (1989). Cytosolic magnesium modulates calcium channel activity in mammalian ventricular cells.
    15. (1995). Determinants of ion specificity on EF-hands sites. Conversion of the Ca2 /Mg2 site of smooth muscle myosin regulatory light chain into a Ca2 -specific site.
    16. (2002). Differential activation by Ca2 , ATP and caffeine of cardiac and skeletal muscle ryanodine receptors after block by Mg2 .
    17. (2000). EF-hand calcium-binding proteins.
    18. (1988). Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes.
    19. (1989). Effects of magnesium on inactivation of the voltage-gated calcium current in cardiac myocytes.
    20. (1999). Electrophysiological remodeling in hypertrophy and heart failure.
    21. (1997). Feedback inhibition of Ca2 channels by Ca2 depends on short sequence of the C terminus that does not include the Ca2 -binding function of a motif with similarity to Ca2 -binding domains.
    22. (2005). Intracellular magnesium enhances voltage-dependent inactivation of CaV1.2 by binding to the C-terminal EF-hand.
    23. (1992). Intracellular pH modulates cytosolic free magnesium in cultured chicken heart cells.
    24. (1998). Loss of cardiac magnesium in experimental heart failure prolongs and destabilizes repolarization in dogs.
    25. (1989). Magnesium ions in cardiac function. Regulator of ion channels and second messengers.
    26. (1994). Magnesium: the fifth but forgotten electrolyte.
    27. (1997). Mechanisms of in vitro cardioprotective action of magnesium on the aging myocardium.
    28. (2004). Modulation of CaV1.2 channels by Mg2 binding to an EF-hand motif in the C-terminal domain.
    29. (1998). Mutations in the EF-hand motif impair the inactivation of barium currents of the cardiac 1C channel.
    30. (2000). Mysteries of magnesium homeostasis.
    31. (1993). Panning transfected cells for electrophysiological studies.
    32. (2001). Phosphorylation-dependent modulation of cardiac calcium current by intracellular free magnesium.
    33. (2004). Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.
    34. (1988). Protein phosphatase-2C from rabbit skeletal muscle and liver: an Mg2 -dependent enzyme. Methods Enzymol.
    35. (1996). Regulation of cardiac Ca2 release channel (ryanodine receptor) by
    36. (2004). Regulation of L-type calcium current by intracellular magnesium in rat cardiac myocytes.
    37. (1996). Specific phosphorylation of a site in the full-length form of the 1 subunit of the cardiac L-type calcium channel by adenosine 3 , 5 -cyclic monophosphate-dependent protein kinase.
    38. (2002). Structural analysis, identification, and design of calcium-binding sites in proteins.
    39. (2000). Structure and regulation of voltage-gated Ca2 channels.
    40. (1996). Structure of the regulatory domain of scallop myosin at 2 Å resolution: implications for regulation.
    41. (2004). Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.